Navigation Links
Diabetes Drug, Exenatide, Good For Blood Sugar Levels and Weight Loss

Eli Lilly and and Amylin Pharmaceuticals has announced that exenatide is very effective in controlling blood sugar levels, at par with iphasic insulin // aspart 30/70 (NovoMix by NovoNordisk). This finding was revealed after a threadbare study conducted by the company. This is indeed a boon to people suffering type 2 diabetes and unable to control the blood sugar with the oral diabetes drugs.

The study, which spanned a year, revealed that thirty-two percent of study participants using exenatide were able to effectively attain the target HbA1C of 7 percent or less. HbA1C is a measure of individuals average glucose level, a gauge commonly used by the specialists. The study also revealed that many patients using exenatide also experienced weight loss, an average of 2.5 kilograms (5.5 pounds), while the patients receiving biphasic insulin aspart had actually gained an average of 2.9 kilograms (6.4 pounds).

"This comparator study demonstrates that exenatide has similar blood glucose control to the conventional treatment with insulin," said Professor Dr. Michael Nauck, Director of the Diabetes Centre in Bad Lauterberg, Germany, and a lead author of the study.

Exenatide happens to be the first among a relatively new class of medicines known as incretin mimetics, which is approved, by the U.S. Food and Drug Administration for the treatment of type 2 diabetes.
'"/>




Page: 1

Related medicine news :

1. Is Diabetes the Leading Cause of Kidney Failure in India
2. Diabetes and Depression often go hand-in-hand
3. Thirty minutes of work up per day reduces the risk of Diabetes
4. Diabetes on the rise
5. Irregular Periods Linked to Diabetes
6. Cinnamon combats Diabetes
7. Good News For Women With Gestational Diabetes
8. Processed Meat, Diabetes connection Found
9. Pancreatic Cancer may be linked to Diabetes
10. Gestational Diabetes linked to Chromosomal defici
11. A way to slow the progression of Type 1 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Diabetes Drug Exenatide Good For Blood Sugar Levels and Weight Loss

(Date:7/30/2014)... Imprivata ® (NYSE: IMPR), ... secure communications solutions for the healthcare industry, today ... most widely selected single sign-on (SSO) solution amongst ... medical records (EMR) systems with a 51 percent ... in the last 12 months), according to HIMSS ...
(Date:7/30/2014)... obese people have a genetic mutation that seems to ... they see food, researchers report. Gaining a better ... and gratification at the sight of high-calorie foods like ... the scientists suggested. More than one-third of U.S. ... a combination of overeating, a lack of physical activity ...
(Date:7/30/2014)... Orange, NJ. July 30, 2014. A new network of ... NIH Stroke Trials Network (NIH StrokeNet) is working ... the U.S. Despite advances of the last two ... year, stroke causes death or disability for 795,000 Americans. ... aging of the population. , To accelerate the ...
(Date:7/30/2014)... The Ehlers-Danlos National Foundation (EDNF) is pleased ... Chack will serve as chair. The board was voted ... Learning Conference in Houston, Texas July 10-12. , ... of us. From the rollout of the first EDNF ... Baltimore Medical Center to our September physicians conference to ...
(Date:7/30/2014)... As the controversy surrounding the use ... continues to grow, Bernstein Liebhard LLP notes that another ... a ban on uterine morcellation. According to a report ... leiomyosarcoma following a hysterectomy that involved the use of ... the aggressive cancer had progressed to Stage 4. Ms. ...
Breaking Medicine News(10 mins):Health News:Imprivata Achieves 51 Percent Single Sign-on Market Share Amongst U.S. Hospitals Using McKesson Paragon or Horizon EMR Systems, According to HIMSS Analytics 2Health News:Gene Mutation May Make Food More Tempting 2Health News:Kessler funded as satellite site for NIH Stroke Trials Network 2Health News:Ehlers-Danlos National Foundation Announces New Leadership 2Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 2Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 3Health News:Power Morcellator Controversy Grows, as Bernstein Liebhard LLP Notes Another Call to Ban Uterine Morcellation 4
... , , , BOISE, Idaho, Dec. 28 The research shows, ... bulge becomes a main priority for those setting New Year resolutions ... war; individuals must be prepared to make lifestyle changes starting with ... Light offer two ways to indulge while working off and managing ...
... , ... Absolutely Public Relations reviews 2009 key media placement results, plus celebrates client and ... anniversary in business, representing the Colorado Cleantech Industry Association, Bell Aquaculture, Colorado BioScience ... , ...
... , WASHINGTON, Dec. 28 CAQH® announced today that ... are the first national health plans to earn certification ... on Operating Rules for Information Exchange® (CORE) Phase II ... in the ongoing development of the CORE rules, which ...
... 28, 2009 -- Children regularly exposed to tobacco smoke ... in adulthood. This finding by researchers at Columbia University,s ... may not recover completely from the effects of early-life ... in the December 2009 American Journal of Epidemiology ...
... , ASHBURN, Va., Dec. ... data capture and enterprise search solutions , today ... France, has selected the company,s Brainware Distiller(TM) solution to automate ... 150 countries and processes hundreds of thousands of invoices and ...
... ... Jack Canfield, Dr. Joe Vitale & Marci Shimoff, Jennifer Nicole Lee is ... and enlightens audiences worldwide with her highly anticipated book "The Mind, Body ... story who has become one of the world,s most accomplished fitness experts. ...
Cached Medicine News:Health News:Make Your 2010 Resolution and Chill Out with Crystal Light Frozen Treats 2Health News:Denver Public Relations Consulting Firm, Absolutely Public Relations, Recaps 2009 Key Media Placement Results, Plus Client and Company Milestones 2Health News:Denver Public Relations Consulting Firm, Absolutely Public Relations, Recaps 2009 Key Media Placement Results, Plus Client and Company Milestones 3Health News:Denver Public Relations Consulting Firm, Absolutely Public Relations, Recaps 2009 Key Media Placement Results, Plus Client and Company Milestones 4Health News:Aetna and WellPoint Achieve CORE Phase II Certification 2Health News:Aetna and WellPoint Achieve CORE Phase II Certification 3Health News:Exposure to tobacco smoke in childhood home associated with early emphysema in adulthood 2Health News:bioMerieux Selects Brainware to Automate Accounts Payable 2Health News:bioMerieux Selects Brainware to Automate Accounts Payable 3Health News:Fitness Celebrity Jennifer Nicole Lee Reveals her Revolutionary Weight Loss Principles in 'The Mind, Body, and Soul Diet' Book 2Health News:Fitness Celebrity Jennifer Nicole Lee Reveals her Revolutionary Weight Loss Principles in 'The Mind, Body, and Soul Diet' Book 3Health News:Fitness Celebrity Jennifer Nicole Lee Reveals her Revolutionary Weight Loss Principles in 'The Mind, Body, and Soul Diet' Book 4
(Date:7/30/2014)... YORK and KISSING, Germany ... and distributor of a single use and computer-assisted ("robotic") ... (Homi) Shamir , a worldwide recognized medical device executive, ... Mr. Shamir is a highly respected global ... recent assignment he served as President and Chief Executive ...
(Date:7/30/2014)... 30, 2014  DigiPath, Inc. (OTCBB and OTCQB: DIGP), ... the cannabis testing and education markets, announced today that ... affairs not previously disclosed or, to its knowledge, any ... action. "We have noticed unusual price and ... trading days," said Steve Barbee , CEO of ...
(Date:7/30/2014)... , July 30, 2014  Lightlake Therapeutics Inc. ... treatments based on its expertise in opioid antagonists, ... commitment from a prominent international research and development ... on promoting innovative research-based initiatives, including those addressing ... spray for the delivery of naloxone that could ...
Breaking Medicine Technology:invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 2invendo medical Appoints Nachum (Homi) Shamir To The Company's Board Of Directors 3DigiPath No New Corporate Developments 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 2Lightlake Therapeutics Inc. Receives Funding Commitment From A Prominent International Research And Development Foundation 3
... Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX ), ... and gastroenterology markets, today announced that it has entered ... a new Phase II development product. The Company has ... Injection and is evaluating the product for the treatment ...
... Inc. (NYSE: CRY ), an implantable biological ... that 2011 first quarter financial results will be released ... Company will hold a teleconference call and live webcast ... followed by a question and answer session hosted by ...
Cached Medicine Technology:Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection 2Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection 3Cumberland Pharmaceuticals Announces New Product Addition With Hepatoren™ (ifetroban) Injection 4CryoLife Announces Release Date and Teleconference Call Details for 2011 First Quarter Financial Results 2
Subretinal Injection Cannula, Straight; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 35°....
Silicone Oil Cannula; 16g (1.40) x 8mm....
Injection Cannula, Straight; 20g (0.90) x 1" (25mm); Tip Extension: 5mm, 30g (0.30)....
...
Medicine Products: